Review: disruption of the postsynaptic density in Alzheimer's disease and other neurodegenerative dementias.
about
Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected miceDevelopment of Novel In Vivo Chemical Probes to Address CNS Protein Kinase Involvement in Synaptic DysfunctionDecreased oligodendrocyte nuclear diameter in Alzheimer's disease and Lewy body dementia.The calcium-binding protein EFhd2 modulates synapse formation in vitro and is linked to human dementia.Schisandra N-butanol extract improves synaptic morphology and plasticity in ovarectomized mice.Investigating perturbed pathway modules from gene expression data via structural equation models.APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.The Notch ligand E3 ligase, Mind Bomb1, regulates glutamate receptor localization in Drosophila.Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathologyModulation of behavior by scaffolding proteins of the post-synaptic density.The central role of heat shock factor 1 in synaptic fidelity and memory consolidationHippocampal synaptic activity, pattern separation and episodic-like memory: implications for mouse models of Alzheimer's disease pathology.Scaffolding proteins of the post-synaptic density contribute to synaptic plasticity by regulating receptor localization and distribution: relevance for neuropsychiatric diseases.Clinical Subtypes of Frontotemporal Dementia.EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease.Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer's Disease.Longitudinal imaging reveals subhippocampal dynamics in glutamate levels associated with histopathologic events in a mouse model of tauopathy and healthy mice.Chronic diabetic states worsen Alzheimer neuropathology and cognitive deficits accompanying disruption of calcium signaling in leptin-deficient APP/PS1 mice.APOE ε4 carriers may undergo synaptic damage conferring risk of Alzheimer's disease.Dose-Dependent Neuroprotection and Neurotoxicity of Simvastatin through Reduction of Farnesyl Pyrophosphate in Mice Treated with Intracerebroventricular Injection of Aβ 1-42.Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.The Memory-Enhancing Effects of Liquiritigenin by Activation of NMDA Receptors and the CREB Signaling Pathway in Mice.Glutamate Transporter GLT1 Expression in Alzheimer Disease and Dementia With Lewy Bodies.Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet-induced systemic inflammation, microglial activation, and reduced neuroplasticityCerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementiasVariation in TMEM106B in chronic traumatic encephalopathyPrion acute synaptotoxicity is largely driven by protease-resistant PrPSc species
P2860
Q27340506-128F71DC-1CAE-4F29-81E5-CF47262CD694Q27679012-93DE1F41-CDFE-45DA-A8EA-F9E5DE22DAACQ34275469-DB5D7FEE-E5B0-4D07-BA40-0A3D47AB331DQ34549505-BDAF892C-1316-49EA-AF02-D153437FD5D1Q35020813-3DDBBC02-A3EA-4DE9-B6CA-DFDE41D53459Q35178635-5F5A22DB-DBEA-4602-A2ED-D81B15D864DFQ35337169-95FC8AFA-5340-4360-8B78-6A9EEB568F11Q36421459-A556225D-4C1E-4228-A5BB-EBF337CB75DCQ36485712-29EEAD78-C159-4F9A-A4E3-635EFB4ADDF5Q37161173-9912DD1C-DE46-4035-A6B9-62153B0CFF64Q37214838-1309EBDC-DAE7-41AD-895D-3BD070A3A118Q37905125-B036EB3F-2D40-4A43-876C-DF968B6CF035Q38044699-54E89EE5-7DFE-48A0-9185-30E2F22D43C2Q38118236-C9EA7249-4CDA-4077-8190-A34BC6BEFE0EQ38733357-9C589F3C-A540-4629-AE88-78E3354C6F48Q39757268-718A8084-F51D-4753-895B-BEAEDDEAB55AQ40415700-0E2E9EB6-8590-4CF7-92A0-D9B093686FA6Q41279397-FE36E5F7-C8FB-4601-B059-2696A0BB959DQ47100604-CFD33B7D-377E-4AE0-8F45-07239FD81CB9Q49012445-3F677010-A800-4E5F-BDDA-F454EEC9EFCCQ49905442-24DC6A5B-5640-4250-9A91-B46791ABDDEEQ50436456-F2AEB6C4-0753-4B70-A264-2B82EBF7052DQ55208633-81BD59A0-1D0D-4B16-A9B1-4B804751F105Q57101020-484B3A3F-4599-4CA8-944E-3F08EC231161Q57750814-1AB58C55-217B-4675-8830-D8C95D843A68Q58612588-1228193F-6334-4309-AC74-0EFB90767BE7Q58795353-F07B075D-408D-4FEC-B119-6FF36C068BA7
P2860
Review: disruption of the postsynaptic density in Alzheimer's disease and other neurodegenerative dementias.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Review: disruption of the post ...... r neurodegenerative dementias.
@en
Review: disruption of the post ...... r neurodegenerative dementias.
@nl
type
label
Review: disruption of the post ...... r neurodegenerative dementias.
@en
Review: disruption of the post ...... r neurodegenerative dementias.
@nl
prefLabel
Review: disruption of the post ...... r neurodegenerative dementias.
@en
Review: disruption of the post ...... r neurodegenerative dementias.
@nl
P2860
P921
P356
P1476
Review: disruption of the post ...... r neurodegenerative dementias.
@en
P2093
Carol F Lippa
Yuesong Gong
P2860
P304
P356
10.1177/1533317510382893
P407
P577
2010-09-21T00:00:00Z